Literature DB >> 22226179

Expression of cytoskeleton and energetic metabolism-related proteins at human abdominal aortic aneurysm sites.

Javier Modrego1, Antonio J López-Farré, Isaac Martínez-López, Miguel Muela, Carlos Macaya, Javier Serrano, Guillermo Moñux.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the expression of proteins related to cytoskeleton and energetic metabolism at abdominal aortic aneurysm (AAA) sites using proteomics. Several remodeling-related mechanisms have been associated with AAA formation but less is known about the expression of proteins associated with cytoskeleton and energetic metabolism in AAAs.
METHODS: AAA samples (6.73 ± 0.40 cm size) were obtained from 13 patients during elective aneurysm repair. Control abdominal aortic samples were obtained from 12 organ donors. Proteins were analyzed using two-dimensional electrophoresis and mass spectrometry.
RESULTS: The expression of filamin was increased in the AAA site compared to control abdominal aortic samples while microfibril-associated glycoprotein-4 isotype 1, annexin A5 isotype 1, and annexin A2 were reduced compared with control abdominal aortic samples. Reduction in expression level of energetic metabolism-associated proteins such as triosephosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, and cytosolic aldehyde dehydrogenase was also observed in AAAs compared to controls. Reduction of triosephosphate isomerase expression was also observed by Western blot, which was accompanied by diminished triosephosphate isomerase activity. At the AAA site, pyruvate dehydrogenase expression was reduced and the content of both lactate and pyruvate was increased with respect to controls without changes in lactate dehydrogenase activity.
CONCLUSIONS: The present results suggest that an anaerobic metabolic state may be favored further to reduce the expression of cytoskeleton-related proteins. The better knowledge of molecular mechanism involved in AAAs may favor development of new clinical strategies.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226179     DOI: 10.1016/j.jvs.2011.10.033

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

2.  Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients.

Authors:  Antonio J López-Farré; Pablo Rodriguez-Sierra; Javier Modrego; Antonio Segura; Naiara Martín-Palacios; Ana M Saiz; José J Zamorano-León; Juan Duarte; Javier Serrano; Guillermo Moñux
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

Review 3.  Proteomic analysis in cardiovascular research.

Authors:  Teiji Oda; Ken-ichi Matsumoto
Journal:  Surg Today       Date:  2015-04-19       Impact factor: 2.549

4.  Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left atrial remodelling.

Authors:  Xianlin Zhang; Hailing Li; Wenxin Kou; Kai Tang; Dongdong Zhao; Jingying Zhang; Jianhui Zhuang; Yifan Zhao; Shuya Ji; Wenhui Peng; Yawei Xu
Journal:  Arch Med Sci       Date:  2018-04-06       Impact factor: 3.318

5.  Pathological investigations and correlation research of microfibrillar-associated protein 4 and tropoelastin in oral submucous fibrosis.

Authors:  Binjie Liu; Wenqun Gou; Hui Feng
Journal:  BMC Oral Health       Date:  2021-11-19       Impact factor: 2.757

Review 6.  The physiological and clinical importance of cardiorespiratory fitness in people with abdominal aortic aneurysm.

Authors:  Maria Perissiou; Tom G Bailey; Zoe L Saynor; Anthony I Shepherd; Amy E Harwood; Christopher D Askew
Journal:  Exp Physiol       Date:  2022-03-18       Impact factor: 2.858

7.  Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions.

Authors:  Helle Wulf-Johansson; Sofie Lock Johansson; Anders Schlosser; Anne Trommelholt Holm; Lars Melholt Rasmussen; Hans Mickley; Axel C P Diederichsen; Henrik Munkholm; Tina Svenstrup Poulsen; Ida Tornøe; Vicki Nielsen; Niels Marcussen; Jørgen Vestbo; Susanne Gjørup Sækmose; Uffe Holmskov; Grith Lykke Sorensen
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

8.  Genetic and Epigenetic Profiling Reveals EZH2-mediated Down Regulation of OCT-4 Involves NR2F2 during Cardiac Differentiation of Human Embryonic Stem Cells.

Authors:  Varsha Pursani; Prasad Pethe; Mohsin Bashir; Prabha Sampath; Vivek Tanavde; Deepa Bhartiya
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.